Rubinsztajn R - Search Results

1

Serum levels of apoptosis-related markers (sFasL, TNF-a, p53 and bcl-2) in COPD patients.

Kosacka M, Porębska I, Korzeniewska A, Rubinsztajn R, Grabicki M, Jankowska R, Batura-Gabryel H, Chazan R. Kosacka M, et al. Among authors: rubinsztajn r. Pneumonol Alergol Pol. 2016;84(1):11-5. doi: 10.5603/PiAP.a2015.0080. Epub 2015 Dec 21. Pneumonol Alergol Pol. 2016. PMID: 26687668 Free article.

2

[Lung cancer in COPD--a clinical analysis].

Maskey-Warzechowska M, Domagała-Kulawik J, Rubinsztajn R, Chazan R. Maskey-Warzechowska M, et al. Among authors: rubinsztajn r. Pol Arch Med Wewn. 2002 Aug;108(2):769-75. Pol Arch Med Wewn. 2002. PMID: 12476897 Polish.

3

[Urinary leukotriene E4 concentration in patients with bronchial asthma and intolerance of non-steroids anti-inflammatory drugs before and after oral aspirin challenge].

Rubinsztajn R, Wrońska J, Chazan R. Rubinsztajn R, et al. Pol Arch Med Wewn. 2003 Aug;110(2):849-54. Pol Arch Med Wewn. 2003. PMID: 14682223 Polish.

4

[Serum leptin concentration and sympathetic activation estimated on the adrenaline and noradrenaline serum concentration in patients with obstructive sleep apnea].

Rubinsztajn R, Kumor M, Byśkiniewicz K, Bielicki P, Chazan R. Rubinsztajn R, et al. Pol Arch Med Wewn. 2005 Jun;113(6):544-51. Pol Arch Med Wewn. 2005. PMID: 16454443 Clinical Trial. Polish.

5

[The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome].

Rubinsztajn R, Kumor M, Byśkiniewicz K, Chazan R. Rubinsztajn R, et al. Pneumonol Alergol Pol. 2006;74(1):63-7. Pneumonol Alergol Pol. 2006. PMID: 17175979 Polish.

6

[The interpretation of carbon monoxide diffusing capacity test depending of hemoglobin concentration].

Rubinsztajn R, Wrotek K, Krenke R, Przybyłowski T, Chazan R. Rubinsztajn R, et al. Pneumonol Alergol Pol. 2006;74(1):113-6. Pneumonol Alergol Pol. 2006. PMID: 17175989 Polish.

7

[Serum concentration of homocysteine and the risk of atherosclerosis in patients with obstructive sleep apnea syndrome].

Kumor M, Rubinsztajn R, Byśkiniewicz K, Bielicki P, Chazan R. Kumor M, et al. Among authors: rubinsztajn r. Pneumonol Alergol Pol. 2006;74(1):117-21. Pneumonol Alergol Pol. 2006. PMID: 17175990 Polish.

8

[Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)].

Kumor M, Bielicki P, Przybyłowski T, Rubinsztajn R, Zieliński J, Chazan R. Kumor M, et al. Among authors: rubinsztajn r. Pneumonol Alergol Pol. 2011;79(3):173-83. Pneumonol Alergol Pol. 2011. PMID: 21509729 Free article. Polish.

9

[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].

Rubinsztajn R, Chazan R. Rubinsztajn R, et al. Pneumonol Alergol Pol. 2011;79(5):343-6. Pneumonol Alergol Pol. 2011. PMID: 21861258 Free article. Polish.

10

Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients.

Paplińska M, Hermanowicz-Salamon J, Nejman-Gryz P, Białek-Gosk K, Rubinsztajn R, Arcimowicz M, Placha G, Góra J, Chazan R, Grubek-Jaworska H. Paplińska M, et al. Among authors: rubinsztajn r. Cytokine. 2012 Nov;60(2):393-9. doi: 10.1016/j.cyto.2012.07.001. Epub 2012 Jul 28. Cytokine. 2012. PMID: 22846146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters